For example, it has been reported that COX-2 inhibition led to decreases in the proliferation of prostate cancer, MDA-MB-435 cancer and PaCa2 pancreatic cancer cells (36–39). The gene discussed is PTGS2; the disease is familial pancreatic carcinoma.